Skip to Content

Karo Pharma AB KARBF Stock Quote

| Rating as of


Market Closed

Chart Data Not Available

No price data available

  • Last Close 5.25
  • Sector Healthcare
  • Industry Drug Manufacturers - Specialty & Generic
  • Investment Style Small Blend
  • Day Range 5.25  –  5.25
  • Year Range 5.25  –  5.76
  • Market Cap 1.4346 Bil
  • Volume / Avg 1,125.0 /  1,075.0
  • Price / Sales 3.32
  • Price / Book 1.78
  • Forward Div Yield 0.63%
  • Trailing Div Yield 4.19%

Morningstar‘s Stock Analysis KARBF

Currency in
Is it the right time to buy or sell?
Is it the right time to buy or sell?

1-Star Price


5-Star Price


Economic Moat


About Quantitative Ratings

Morningstar Quantitative ratings for equities (denoted on this page by) are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies withratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating. Click here for more on how to use these ratings.

Unlock Our Full Analysis With Morningstar Investor

Key Statistics KARBF

Company Profile KARBF

Business Description

Karo Pharma AB is a healthcare corporation. It is primarily engaged in the business activity of developing and marketing products to pharmacies and directly to the healthcare sector. The trademarks of the firm are Ibux, Paracet, Dosett, Allevo, and Swereco. It operates in the segment of research and development for drug discovery. The company carries its business operations in Sweden and internationally, of which the majority of the revenue is generated from Sweden and Norway.

Klara Norra Kyrkogata 33
Stockholm, 111 22, SWE
Industry Drug Manufacturers - Specialty & Generic
Employees 225

Competitors & Peers KARBF

Morningstar does not cover competitors or peers for this firm.

FAQs for Karo Pharma AB Stock

No. KARBF does not currently have a forward dividend yield.
Dividend yield allows investors, particularly those interested in dividend-paying stocks, to compare the relationship between a stock’s price and how it rewards stockholders through dividends. The formula for calculating dividend yield is to divide the annual dividend paid per share by the stock price.

Learn more about dividend yield.

KARBF’s market cap is 1.43 Bil.
Market capitalization is calculated by taking a company’s share price and multiplying it by the total number of shares. It’s often used to measure a company’s size. In the Morningstar Style Box, large-cap names account for the largest 70% of U.S. stocks, mid-cap names account for the largest 70–90%, and small-cap names are the remaining 10% of companies.

Learn more about market capitalization.

KARBF’s stock style is Small Core.
Style is an investment factor that has a meaningful impact on investment risk and returns. Style is calculated by combining value and growth scores, which are first individually calculated.

High-growth stocks tend to represent the technology, healthcare, and communications sectors. They rarely distribute dividends to shareholders, opting for reinvestment in their businesses. More value-oriented stocks tend to represent financial services, utilities, and energy stocks. These are established companies that reliably pay dividends.

Learn more about style.

KARBF’s beta can be found in Trading Information at the top of this page.
A stock’s beta measures how closely tied its price movements have been to the performance of the overall market.

Compare KARBF’s historical performance against its industry peers and the overall market.